A Division of Fordham Financial Management, Inc

17 State Street, 22nd Floor

New York, New York 10004


  October 30, 2020




United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549


  Re: Inhibikase Therapeutics, Inc. (the “Company”)

Registration Statement on Form S-1, as amended (the “Registration Statement”)

File No. 333-240036


Ladies and Gentlemen:


On October 27, 2020, ThinkEquity, a division of Fordham Financial Management, Inc. (“ThinkEquity”), as representative of the underwriters of the offering, joined in the request of the Company that the effective date of the above-referenced Registration Statement on Form S-1 be accelerated so as to permit it to become effective on Thursday, October 29, 2020, at 5:00 p.m. (Eastern Time), or as soon thereafter as practicable. The undersigned, on behalf of ThinkEquity, hereby withdraws such request. 


  Very truly yours,
  a division of Fordham Financial Management, Inc.
  By: /s/ Eric Lord  
  Name:   Eric Lord
  Title: Head of Investment Banking


cc:Leslie Marlow, Esq.

Patrick J. Egan, Esq.